Investor Presentaiton

31st January 2024 US takes the lead for overall growth 8% 11% 33% 10% 9M Consolidated Branded Generics (Rs. Cr.) USA Generics (Rs. Cr.) Africa Institution (Rs. Cr.) 188 2,23 703 2,83 7 Consolidated Sales (Rs. Cr.) 3,12 1 2,06 5 0 631 141 ■9M FY23 ■9M FY24 9M FY23 9M FY24 ■9M FY23 9M FY24 71% of Total Revenue 23% of Total Revenue 6% of Total Revenue 9M FY23 9M FY24 29 ajanta

View entire presentation